文化大學機構典藏 CCUR:Item 987654321/26915
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 46867/50733 (92%)
Visitors : 11872692      Online Users : 410
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/26915


    Title: Sorafenib induces autophagy and suppresses activation of human macrophage
    Authors: Lin, JC (Lin, Jiunn-Chang)
    Liu, CL (Liu, Chien-Liang)
    Lee, JJ (Lee, Jie-Jen)
    Liu, TP (Liu, Tsan-Pai)
    Ko, WC (Ko, Wen-Chin)
    Huang, YC (Huang, Yu-Chuen)
    Wu, CH (Wu, Chih-Hsiung)
    Chen, YJ (Chen, Yu-Jen)
    Contributors: Grad Inst Sport Coaching Sci
    Keywords: Sorafenib
    Macrophage
    Autophagy
    Date: 2013-02
    Issue Date: 2014-03-03 10:22:48 (UTC+8)
    Abstract: Background: Sorafenib, a multi-kinase inhibitor approved for treatment of advanced renal cell carcinoma and other malignancies, has been shown as a modulator for dendritic cells. This study was designed to examine the effects of sorafenib on macrophages, the major ontogeny of innate immunity.

    Materials and methods: Macrophages were derived from sorted CD14(+) monocytes of human peripheral blood mononuclear cells. Cell viability and surface antigens were examined by trypan blue analysis. Autophagy was characterized by light microscopy and transmission electron microscopy for morphology, Western blotting for microtubule associated light chain protein 3B (LC-3B) I lipidation, and acridine orange staining for acidic component vacuoles. Soluble factors contained in culture medium and serum were measured by ELISA.

    Results: We found that sorafenib inhibited the viability of macrophages accompanied by morphological changes characteristic of autophagy. This autophagy-inducing effect was validated by LC3B-I lipidation and autophagosome accumulation. The surface antigen expression and the function of activated macrophages were inhibited by sorafenib, including the expression of co-stimulatory molecule CD80, phagocytosis, and the production of reactive oxygen species. The secretion of IL-10, but not IL-6, TNF-alpha nor TGF-beta, was reduced by sorafenib.

    Conclusion: Sorafenib, in addition to being a cancer targeted therapeutic agent, can induce autophagy and modulate the function of human macrophages. (C) 2013 Elsevier B.V. All rights reserved.
    Relation: INTERNATIONAL IMMUNOPHARMACOLOGY Volume: 15 Issue: 2 Pages: 333-339
    Appears in Collections:[Graduate Institute of Sport Coaching Science ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML469View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback